CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 20 No. 11
Pages: 1  2  
Next
BOOK REVIEW 

MD Anderson Manual of Medical Oncology

By Reviewed by
James A. Stewart, MD, FACP
Professor
University of Wisconsin
School of Medicine
and Public Health
Hematology-Oncology Section
Department of Medicine and
University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin | October 1, 2006

Editors: Hagop M. Kantarjian
Robert A. Wolff, and
Charles A. Koller
Publisher:
McGraw Hill, New York
1,149 pages
Price: $195.00


It is an unusual oncologist in the United States who has not had a patient receive a second opinion at the M. D. Anderson Cancer Center (MDA). Long a respected and well-known force in cancer research and patient care, MDA has exerted significant national and international influence not only with scientific publications but also through its training programs and large clinical operation. This book will add to that influence with concise disease-oriented chapters covering the patient population a medical oncologist will see in practice. The MD Anderson Manual of Medical Oncology is not a small handbook. Rather, it is a hardbound text of more than 1,000 pages authored by nearly 100 MDA clinicians.

The 13 sections contain a total of 44 chapters generally organized by disease category, much as clinical activities are designed at large cancer centers. The book is physically structured so as to be easy to read. First-year fellows, for example, could easily digest a chapter a day early in their training and receive a solid perspective on treatment trends and controversies. There are two columns of text per page, and each chapter contains multiple illustrations, figures, tables, treatment flow diagrams, or decision algorithms. Some of the algorithms are complex with opportunity for error. For example, in one for metastatic breast cancer, a label for "previously used taxane treatment" is missing, causing some confusion for the reader. The color photographs of pathologic specimens, endoscopy pictures, or histology examples are generally of excellent quality. Radiologic images are also put to good use, highlighting key points in the text.

Most of the chapters do indeed capture the sense of "How we do it at MDA," which is what this manual is all about. The chapter on colorectal cancer has an interesting section titled, "The MDACC Approach to Patients with Metastatic Disease." Here, the authors describe broad principles that drive their treatment recommendations. Not all readers will agree with some of their approaches, but the authors are clear in the rationale for treatment of metastatic disease in asymptomatic patients, and it is refreshing to see such commentary in print. Some more encyclopedic cancer texts can overwhelm the reader with data and references but come up short in terms of clinical advice. In that sense, this book is more of a manual than a comprehensive text, and oncology fellows should not mistake reading a chapter as being exposed to the basic science, treatment development history, and multidisciplinary approaches that are essential in oncology training.

The audience for this book would include a variety of clinicians. As mentioned, it is a nice reference for fellows as they rotate through the different clinics. In many large cancer programs, attending clinicians devote their efforts to one disease. It is easy to become outdated in the other diseases, and this book will provide a nice review. Likewise, this would be a good reference for family practitioners or general internists who may be involved in helping to counsel a patient being treated for cancer. Too often, generalists can shy away from helping patients in the decision-making process. This book is a nice resource for them to get a relatively quick sense of treatment strategies and controversies.

An important chapter called "Adult Long-Term Follow-Up" is placed near the end of the book. In future editions, it might be better to place it near the beginning since the importance of this topic will only grow. Cancer survivorship research will need to expand, and oncologists will need to work with primary care clinicians to develop strategies that will enhance high-quality long-term survivorship. The authors are to be commended for including this chapter.

The references for each chapter are quite current for a hardbound book. Many chapters include 2005 references. The editors have done an excellent job in maintaining reasonable uniformity of style across chapters without diminishing author/clinic individuality. It will be a challenge to keep the manual current, as treatment strategies for many diseases change fairly rapidly.

In summary, this book is clearly an MDA product, and from my experience, the authors do in fact preach what they practice. No book can replace a real second opinion with doctor-patient face-to-face discussion, but it does provide a look at what your patient might hear if they visit MDA. It is not a comprehensive textbook of all elements of cancer biology and multidisciplinary care. Rather, the manual provides a readable review of medical treatment approaches to cancers treated with chemotherapy. As a manual should, it provides concise treatment descriptions in a volume that should be readily available for reference. With this focus, this text is a unique and valuable addition to clinically oriented oncology books.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Victor Bove | June 29, 2010 5:15 AM EDT

The MCO of the MD Anderson is well nown in oncologist services.

Very usefull for us






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy